Skip to main content

Peer Review reports

From: Remission effect of Canagliflozin in patients with newly diagnosed type 2 diabetes mellitus: a protocol for a multicenter, parallel-group, randomized, controlled, open-label trial

Original Submission
11 Feb 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
25 Apr 2023 Reviewed Reviewer Report
28 Aug 2023 Reviewed Reviewer Report
10 Sep 2023 Author responded Author comments - Chao Liu
Resubmission - Version 5
10 Sep 2023 Submitted Manuscript version 5
12 Sep 2023 Author responded Author comments - Chao Liu
Resubmission - Version 6
12 Sep 2023 Submitted Manuscript version 6
16 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
16 Sep 2023 Editorially accepted
10 Oct 2023 Article published 10.1186/s12902-023-01461-9

You can find further information about peer review here.

Back to article page